Timber Pharmaceuticals, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$12.6M

179 transactions

Summary

Timber Pharmaceuticals, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $2.3MSales: $3.7M28 insiders

Date	Insider	Type	Value
2022-12-15	Sitar Edward J	A	$4K
2023-08-20	Lucchese Joseph(EVP & CFO)	A	$0
2023-08-20	Mendelsohn Alan(EVP & CMO)	A	$0
2023-08-20	Koconis John(CEO & Chairman)	A	$0
2023-04-15	Lucchese Joseph(EVP & CFO)	A	$0
2023-04-15	Cohen David E	A	$0
2023-04-15	Cohen David E	A	$0
2023-04-15	Sitar Edward J	A	$0
2023-04-15	Sitar Edward J	A	$0
2023-04-15	Pirozzi Gianluca	A	$0
2023-04-15	Pirozzi Gianluca	A	$0
2023-04-15	Mendelsohn Alan(EVP & CMO)	A	$0
2023-04-15	Gaal Lubor	A	$0
2023-04-15	Gaal Lubor	A	$0
2023-04-15	Koconis John(CEO & Chairman)	A	$0
2022-04-15	Gaal Lubor	A	$0
2022-04-15	Gaal Lubor	A	$0
2022-04-15	Pirozzi Gianluca	A	$0
2022-04-15	Pirozzi Gianluca	A	$0
2022-04-15	Sitar Edward J	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Timber Pharmaceuticals, Inc. — Contributions, Lobbying & Contracts | Poliscope